Sertraline HCL National Contract
ID: SPE2D2-15-R-0014Type: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/e58d686529174beb8cc6c0b1e644cb91/view
Timeline
    Description

    Presolicitation notice for a national contract for Sertraline HCL. Sertraline HCL is a medical/dental/veterinary equipment/supply used for the treatment of depression, panic attacks, obsessive-compulsive disorder, post-traumatic stress disorder, and social anxiety disorder. Contact Danielle Delaney at Danielle.Delaney@dla.mil or 215-737-2998 for more information.

    Point(s) of Contact
    Catherine Gilbert
    (215) 737-4778
    catherine.gilbert@dla.mil
    Denise Taubman
    (215) 737-8677
    denise.taubman@dla.mil
    Files
    Title
    Posted
    Amendment_0001.pdf
    Amendment_0002.pdf
    Bilateral_Signed_P00003.pdf
    PDF_Final_Solicitation.pdf
    Sertraline_Option_1_mod.pdf
    SF30_SPE2D216D0032P00004.pdf
    Word_Final_Solicitation.docx
    Lifecycle
    Title
    Type
    Sertraline HCL National Contract
    Currently viewing
    Presolicitation
    Similar Opportunities
    Duloxetine HCL DR
    Active
    Dept Of Defense
    Presolicitation notice for Duloxetine HCL DR. The service/item being procured is typically used for medical, dental, and veterinary equipment and supplies. The place of performance is in Philadelphia, PA, USA at DLA Troop Support, 700 Robbins Avenue, 19111. The primary contact for this procurement is Joan Grace, who can be reached at JoanMarie.Grace@dla.mil or 215-737-2663.
    Trazodone HCL
    Active
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is procuring Trazodone HCL, a drug used for treating depression and anxiety. The procurement will take place at DLA Troop Support in Philadelphia, PA (zip code: 19111), USA. For more information, contact Christopher Newman at christopher.newman@dla.mil or 215-737-2905.
    6505--Zolmitriptan Tablets (VA-25-00006129)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Zolmitriptan tablets, as outlined in solicitation number VA-25-00006129. This contract aims to establish a reliable source of pharmaceutical supplies for federal healthcare programs, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and good manufacturing practices as mandated by the FDA. The selected contractor will be responsible for providing competitive pricing for both the base year and four option years, ensuring that all products meet safety and regulatory standards. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details and to discuss submission requirements.
    ESCITALOPRAM OXALATE PRE SOLICITATION SPE2D218R0022 CANCELLED
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is cancelling the pre-solicitation notice for the procurement of Escitalopram Oxalate Tablets. No solicitation will be issued under this pre-solicitation number SPE2D2-18-R-0022. Escitalopram Oxalate Tablets are typically used as a medication for the treatment of depression and anxiety disorders.
    SPE2D220R0063 BUPROPION XL AMENDMENT 0002
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is seeking BUPROPION XL. This procurement is for drugs and biologicals under PSC code 6505. The primary contact for this procurement is Catherine Gilbert (catherine.gilbert@dla.mil, 2157374778) and the secondary contact is Denise Taubman (denise.taubman@dla.mil, 2157376877). The notice includes Amendment 0002, which incorporates telecommunication clauses. The solicitation is not reopened and the closing date is not extended. BUPROPION XL is typically used for medical purposes.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used for treating high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties can contact Catherine Gilbert for more information. The solicitation is projected to be issued in December 2019.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used to treat high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The solicitation will be posted on the DLA Bid Board System and beta.SAM.gov, with a projected solicitation date in June 2021. Interested parties should contact Christopher Newman for more information.
    Telmisartan Tablets
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Telmisartan Tablets. Telmisartan Tablets are pharmaceutical preparations used to treat high blood pressure and reduce the risk of heart attack, stroke, and kidney problems in certain patients. The tablets will be available in 20MG, 40MG, and 80MG strengths, packaged in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The contract aims to establish a national supply source to provide Telmisartan Tablets to Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. Interested parties can contact Courtney Hunter-Stangler at (215) 737-6845 or Courtney.Hunter-Stangler@dla.mil for any questions/comments. The solicitation is projected to be issued in August of 2024.
    Rizatriptan Benzoate
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Rizatriptan Benzoate tablets. The contract will establish a national supply source to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The solicitation will be posted on the DLA Bid Board System and SAM.gov. Interested parties should contact Keith Ryales for any questions/comments. The projected solicitation date is June 2022.
    Ondansetron 4MG and 8MG
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Ondansetron. This contract will establish a national supply source to provide Ondansetron HCL 4 and 8MG Tablets for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The projected solicitation date is March of 2023.